Video Colonoscopes – i10 Series HD+
The i10 Series HD+ Colonoscopes are PENTAX Medical’s premium line of endoscopes for screening, diagnostic and therapeutic treatment in the lower GI tract. The i10 Colonoscopes are available in both standard and slim insertion tube diameters and both equipped with a large 3.8mm instrument channel. The i10 Series HD+ Colonoscopes deliver the best imaging, therapeutic opportunity and ergonomic comfort within the PENTAX Medical Colonoscopy Product Line.
Next generation imaging system with HD+™ CCDs, CloseFocus™ and i-SCAN™
The i10 Series HD+ Colonoscopes are equipped with second-generation HD+ Megapixel Resolution CCDs for exceptional image clarity and detail resolution. Both scopes can be used with i-SCAN™ image enhancement technology that provides the user with an enhanced view of the texture of the mucosal surface and the blood vessels. The EC34-i10L features CloseFocus™ Examination Range allows the physician to get as close as 2mm from the mucosa for even greater resolving power and magnified visualization of the tissue and capillary networks automatically, without the need for button activation.
Improved ergonomic design and control
Endoscopist’s daily procedure volume is growing and putting more pressure on the endoscopist to do more cases and reduce procedure times. The i10 Series HD+ Colonoscopes are designed with a new ergonomic control body to better support higher case volumes and overall comfort in the physician’s hand. With PENTAX Medical i-FLEX™ Graduated Stiffness Insertion Tubes featuring TrueTorque™ Design, the i10 Series HD+ Colonoscopes are designed to balance efficiency, consistency and patient comfort in colonoscopy.
HOYA Group PENTAX Medical is invited to The United Nations Meeting on Improved Global Infection Prevention and Control and Reduce Antimicrobial Resistance
Tokyo – HOYA Group PENTAX Medical is invited to the United Nations General Assembly Meeting titled as “Working together across the Public and Private Sectors to Address Antimicrobial Resistance” on September 21st, 2016.
The meeting is an invitation only event at the United Nations focusing on collaboration between the public and private sectors to address AMR (antimicrobial resistance), through improved infection prevention and control, diagnostic testing, surveillance and reporting. In the history of the United Nations, the General Assembly has only held high-level meetings on health issues three times for HIV, Ebola, and chronic diseases like diabetes and obesity. Today’s event is historic as it recognizes the critical importance of intervention to prevent further resistance to these dangerous pathogens.
The background is the worldwide common needs for infection control and antibiotic superbugs. Participants are thought leaders from the World Health Organization (WHO), the Director of the US Centers for Disease Control and Prevention (CDC), the National Institutes of Health, the London School of Hygiene and Tropical Medicine, and The Japan Ministry of Health.
“This is quite an honor for us to be the only one endoscope manufacturer invited and participating in these collaborative discussions about this global challenge” says Dr. Hudson Garrett, Global Chief Clinical Officer, PENTAX Medical. “We are committed to contribute to raise the bar of infection control for patient safety across the continuum of care globally in all markets that we serve.”
About PENTAX Medical
PENTAX Medical is a division of HOYA Group. Its mission is to improve the standard of patient care and quality of healthcare delivery by providing the best endoscopic products and services with a focus on QUALITY, CLINICALLY RELEVANT INNOVATION, and SIMPLICITY. Through leading edge R&D and manufacturing, PENTAX Medical provides endoscopic imaging devices and solutions to the global medical community. Headquartered in Japan, PENTAX Medical has a worldwide focus and presence with R&D, regional sales, service, and in-country facilities around the globe.
GM, Global Marketing Communication
InfectionControl.tips Appoints PENTAX Medical's Global Chief Clinical Officer, Dr. Hudson Garrett Jr., to Their Global Advisory Board